Clinic
Miami Valley Urgent Care LLC
Miami Valley Urgent Care LLC was paid $2.10M by Medicaid between Jan 2018 and Dec 2024, across 25 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 57% of everything it billed.
33Billing provider infoMIAMI VALLEY URGENT CARE LLC
DAYTON, OH 45432
DAYTON, OH 45432
33aNPI1649209784assigned 07/01/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$2.10M
24GClaims47,430
24DCodes billed25
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Ohio
Rank by total paid#16 of 95
Median peer was paid$201K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,593 | $446K | |
| 2019 | 10,345 | $441K | |
| 2020 | 8,174 | $308K | |
| 2021 | 5,272 | $246K | |
| 2022 | 5,149 | $252K | |
| 2023 | 5,387 | $247K | |
| 2024incomplete | 3,510 | $161K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 57% | 20,256 | 19,433 | $1.20M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 30% | 10,569 | 10,265 | $621K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.5% | 1,890 | 1,752 | $116K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.0% | 1,005 | 931 | $63K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.1% | 908 | 829 | $43K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 363 | 343 | $23K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 937 | 878 | $11K |
| 99201 | <1% | 242 | 229 | $11K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,451 | 2,316 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,049 | 978 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 983 | 699 | $2K |
| 81025 | <1% | 475 | 417 | $1K |
13 more codes
| 81002 | <1% | 854 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 225 | $921.25 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 163 | $643.40 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 39 | $364.76 |
| 81003 | <1% | 269 | $341.14 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 84 | $285.51 |
| 87400 | <1% | 13 | $70.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 55 | $59.81 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 16 | $19.21 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 29 | $3.04 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 28 | $1.80 |
| 99000 | <1% | 4,454 | $1.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 73 | $0.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUPTA, GARIMA (CREDENTIALING SPECIALIST)
| Provider | Location | Paid |
|---|---|---|
| Miami Valley Ambulatory Surgery Center LTD | Dayton, OH | $2.14M |
| Dayton Outpatient Center INC | Dayton, OH | $84K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.